Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Neurocrine Bioscienc (NBIX)

70.59 -3.16 (-4.28%)

12-11 16:00

Open:

74.06

Pre. Close:

73.75

High:

74.12

Low:

70.48

Volume:

976,977

Market Cap:

6247M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

75.18 - 76.19

76.19 - 77.39

Low:

67.83 - 68.63

68.63 - 69.58

Close:

68.71 - 70.55

70.55 - 72.73

Technical analysis  (as of: 2017-12-11 4:49:53 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 84.89     One year: 88.74

Support:

Support1: 67.33    Support2: 56.02

Resistance:

Resistance1: 72.68    Resistance2: 75.98

Pivot:

71.46

Moving Averages:

MA(5): 71.53     MA(20): 71.87

MA(100): 60.76     MA(250): 51.53

MACD:

MACD(12,26): 1.08     Signal(12,26,9): 1.46

%K %D:

%K(14,3): 61.34     %D(3): 55.38

RSI:

RSI(14): 50.56

52-Week:

High: 75.98  Low: 37.35  Change(%): 62.6

Average Vol(K):

3-Month: 90330  10-Days 84101

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NBIX has closed above bottom band by 37.1%. Bollinger Bands are 21.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 16 Aug 2017 15:33:45 GMT
Neurocrine Biosciences: Ingrezza's Strong Launch, Pipeline To Create Value

Tue, 12 Dec 2017 12:00:00 GMT
Choosing Between Neurocrine Biosciences, Inc. (NBIX) and Mylan NV (MYL)?

Mon, 20 Nov 2017 21:04:39 GMT
Neurocrine Biosciences Appoints Matt Abernethy as Chief Financial Officer

Tue, 21 Nov 2017 18:11:15 GMT
Neurocrine Biosciences to Present at the 29th Annual Piper Jaffray Healthcare ...

Mon, 04 Dec 2017 21:00:00 GMT
Neurocrine Biosciences (NBIX) Presents Long-term Data Analyses from Open-label ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

88.49

Shares Float (M)

82.22

% Held by Insiders

1.19

% Held by Institutions

111.40

Shares Short (K)

8670

Shares Short Prior Month (K)

8380

Stock Financials

EPS

-2.220

EPS Est. Current Year

-2.450

EPS Est. Next Year

-1.700

EPS Est. Next Quarter

-0.410

Forward EPS

-0.290

Book Value (p.s.)

3.930

PEG Ratio

-1.08

Profit Margin

-289.22

Operating Margin

-282.30

Return on Assets (ttm)

-20.2

Return on Equity (ttm)

-55.5

Qtrly Rev. Growth

Gross Profit (p.s.)

0.170

Sales Per Share

EBITDA (p.s.)

-2.117

Qtrly Earnings Growth

Operating Cash Flow (M)

-166.53

Levered Free Cash Flow (M)

-105.55

atoplab.com

Valuation

P/E

-31.80

P/E Growth Ratio

-0.04

P/BV

17.96

P/S

8112349184.00

P/CF

-37.51

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

1995-12-29

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.